PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15
Media Pack
News

Current Edition

Issue 9 Volume 1

Upcoming Events

Scientific Lab Show
SLAS
Bio IT
PEGS Boston
ELRIG Drug Discovery USA
Biotechnology Show 13.02.26
PFS & Injectable drug devices west coast
PFS & Injectable Drug Devices East Cost
Bio Trinity
Anglo Nordic

Advertisement

A&M Stabtest April 26
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025
QMB Innovation Centre
Polypure hompage
news

Nektar, Bristol Myers drug combination fails in late-stage melanoma trial

Dive Brief: Shares in Nektar Therapeutics fell by more than half Monday morning after the San Francisco biotech company and partner Bristol Myers Squibb disclosed ...
21 March 2022 news Biotech | Bristol Myers
Continue Reading →
news

Bristol Myers returns to Immatics for a dual-targeting cancer drug

Bristol Myers' acquisition of Celgene immediately made the big pharma a top player in the development of cancer cell therapies. Since the deal closed, Bristol Myers h...
15 December 2021 news Breyanzi | Bristol Myers
Continue Reading →
news

Bristol Myers’ top autoimmune drug prospect takes a hit in mid-stage trial

Deucravacitinib is important to Bristol Myers for several reasons. The drug is seen as a potential top-seller, leading a new class of oral drugs that could challenge...
8 October 2021 news anti-inflammatory medicine | autoimmune
Continue Reading →
The Bridge 28.01
Newcells 3 June 2024, 15:12
Richter: Wed 23 October 2024, 09:03
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025
Crown Bioscience 08.09.2025
Aseptic Tech
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2026, All Rights Reserved – Powered by Teksyte